Lv Y - Search Results

1

miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2.

Wang Q, Jiang F, Zhao C, Song J, Hu M, Lv Y, Duan Y, Fang W, Ding R, Qiu Y. Wang Q, et al. Among authors: lv y. Heliyon. 2023 Apr 19;9(5):e15451. doi: 10.1016/j.heliyon.2023.e15451. eCollection 2023 May. Heliyon. 2023. PMID: 37131441 Free PMC article.

2

Circulating microRNAs in Response to Exercise Training in Healthy Adults.

Zhou Q, Shi C, Lv Y, Zhao C, Jiao Z, Wang T. Zhou Q, et al. Among authors: lv y. Front Genet. 2020 Mar 18;11:256. doi: 10.3389/fgene.2020.00256. eCollection 2020. Front Genet. 2020. PMID: 32256529 Free PMC article.

3

Circulating Non-coding RNAs and Cardiovascular Diseases.

Zhao C, Lv Y, Duan Y, Li G, Zhang Z. Zhao C, et al. Among authors: lv y. Adv Exp Med Biol. 2020;1229:357-367. doi: 10.1007/978-981-15-1671-9_22. Adv Exp Med Biol. 2020. PMID: 32285424 Review.

4

Diagnosis of acute myocardial infarction using a combination of circulating circular RNA cZNF292 and clinical information based on machine learning.

Zhou Q, Boeckel JN, Yao J, Zhao J, Bai Y, Lv Y, Hu M, Meng D, Xie Y, Yu P, Xi P, Xu J, Zhang Y, Dimmeler S, Xiao J. Zhou Q, et al. Among authors: lv y. MedComm (2020). 2023 Jun 13;4(3):e299. doi: 10.1002/mco2.299. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37323876 Free PMC article.

5

MicroRNAs in heart and circulation during physical exercise.

Wang L, Lv Y, Li G, Xiao J. Wang L, et al. Among authors: lv y. J Sport Health Sci. 2018 Oct;7(4):433-441. doi: 10.1016/j.jshs.2018.09.008. Epub 2018 Sep 25. J Sport Health Sci. 2018. PMID: 30450252 Free PMC article. Review.

6

Plant mass variations of Leymus chinensis (Poaceae) and their relationships with environmental factors on a large-scale gradient, northeastern China.

Zheng Y, Xue J, Lv Y, Zhang C, Wang R. Zheng Y, et al. Among authors: lv y. Ecol Evol. 2024 May 15;14(5):e11215. doi: 10.1002/ece3.11215. eCollection 2024 May. Ecol Evol. 2024. PMID: 38751822 Free PMC article.

7

A case report of low-dose apatinib in the treatment of advanced triple-negative breast cancer.

Lv Y, Zhang H, Zhao Y, Zhang H, Wang T. Lv Y, et al. Transl Breast Cancer Res. 2024 Jan 11;5:8. doi: 10.21037/tbcr-23-24. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 38751676 Free PMC article.

8

Antibody-drug conjugate monotherapy refines the oncological efficacy as compared to therapy of physicians' choices in advanced breast cancers: a systematic review and meta-analysis.

Song Y, Lv Y. Song Y, et al. Among authors: lv y. Transl Breast Cancer Res. 2023 Apr 30;4:11. doi: 10.21037/tbcr-23-14. eCollection 2023. Transl Breast Cancer Res. 2023. PMID: 38751489 Free PMC article.

9

Molecular mechanisms of Tetrastigma hemsleyanum Diels&Gilg against lung squamous cell carcinoma: From computational biology and experimental validation.

Li P, Wang C, Chen G, Han Y, Lu H, Li N, Lv Y, Chu C, Peng X. Li P, et al. Among authors: lv y. J Ethnopharmacol. 2024 May 13:118326. doi: 10.1016/j.jep.2024.118326. Online ahead of print. J Ethnopharmacol. 2024. PMID: 38750988

10

A CT based radiomics analysis to predict the CN0 status of thyroid papillary carcinoma: a two- center study.

Li Z, Zhong Y, Lv Y, Zheng J, Hu Y, Yang Y, Li Y, Sun M, Liu S, Guo Y, Zhang M, Zhou L. Li Z, et al. Among authors: lv y. Cancer Imaging. 2024 May 15;24(1):62. doi: 10.1186/s40644-024-00690-y. Cancer Imaging. 2024. PMID: 38750551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,129 results

Search Page